- Page 2:
TÍTULO: Influencia de la época de
- Page 5:
3.I.A. 3.I.B. 3.II.A. 3.II.B.
- Page 9 and 10:
Rate /100 patient-year 20 15 10 5 0
- Page 11 and 12:
4
- Page 13 and 14:
6
- Page 16 and 17:
9
- Page 18 and 19:
o o o o
- Page 20 and 21:
úá ó ú ñ
- Page 22 and 23:
• •
- Page 24 and 25:
• •
- Page 26 and 27:
19
- Page 28 and 29:
• • •
- Page 30 and 31:
• •
- Page 32 and 33:
• •
- Page 34 and 35:
Los resultados de esta tesis se han
- Page 36 and 37:
1.II.A. 1.II.B. 1.II.C.
- Page 38 and 39:
• • • •
- Page 40 and 41:
2.000 10000 Media Lista Espera (Dí
- Page 42 and 43:
55 70 50 60 Mean Edad Receptor 45 4
- Page 44 and 45:
70 60 60 50 Edad Receptor (Años) 5
- Page 46 and 47:
• •
- Page 48 and 49:
Supervivencia Acumulada Paciente 1,
- Page 50 and 51:
• •
- Page 52 and 53:
45
- Page 54 and 55:
o í
- Page 56 and 57:
1,0 1,0 1,0 Supervivencia Acumulada
- Page 58 and 59:
51
- Page 60 and 61:
53
- Page 62 and 63:
150 PCR_CMV Missing NEGATIVO POSITI
- Page 64 and 65:
• • •
- Page 66 and 67:
200 150 100 50
- Page 68 and 69:
o
- Page 70 and 71:
o
- Page 72 and 73:
65
- Page 74 and 75:
67
- Page 76 and 77:
o í í
- Page 78 and 79:
•
- Page 80 and 81:
o
- Page 82 and 83:
75
- Page 84 and 85:
77
- Page 86 and 87:
79
- Page 88 and 89:
• Estado del paciente al a
- Page 90 and 91:
83
- Page 92 and 93:
85
- Page 94 and 95:
40 N=389 ¿10º año post-Tx? 120 E
- Page 96 and 97:
89
- Page 98 and 99:
Supervivencia Paciente Supervivenci
- Page 100 and 101:
93
- Page 102 and 103:
95
- Page 104 and 105:
20 15 10 5 0 Vida Media (Años) Vid
- Page 106 and 107:
20 Vida Media Años N 40 15 30 10 2
- Page 108 and 109:
101
- Page 110 and 111:
Q1 Q2 Q3 Q4 0,25 0,2 Mortalidad Acu
- Page 112 and 113:
105
- Page 114 and 115:
Q1 Q2 Q3 Q4 Lineal (Q1) Lineal (Q2)
- Page 116 and 117:
0,55 0,5 0,45 Q1 Q2 Q3 Q4 Lineal (Q
- Page 118 and 119:
111
- Page 120 and 121:
113
- Page 122 and 123:
INTERVALOS TFG < 6m TFG 6-12m Trasp
- Page 124 and 125:
3.I.A. 3.I.B. 3.II.A. 3.II.B.
- Page 126 and 127:
100 80 60 40 20 0 * C-Gault MDRD-7
- Page 128 and 129:
100 180 160 80 60 40 20 0 C-G
- Page 130 and 131:
123
- Page 132 and 133:
125
- Page 134 and 135:
TFG (ml/min/1.73 m2) 60 50 40 30 20
- Page 136 and 137:
129
- Page 138 and 139:
30 120 100 Estadios Empeora Estable
- Page 140 and 141:
133
- Page 142 and 143:
135
- Page 144 and 145:
137
- Page 146 and 147:
139
- Page 148 and 149:
141
- Page 150 and 151:
143
- Page 152 and 153:
145
- Page 154 and 155:
147
- Page 156 and 157:
3.V.B.
- Page 158 and 159:
151
- Page 160 and 161:
153
- Page 162 and 163:
• •
- Page 164 and 165:
Supervivencia Acumulada Tx 1,0 0,8
- Page 166 and 167:
Supervivencia Acumulada Tx Censuran
- Page 168 and 169:
•
- Page 170 and 171:
Supervivencia Acumulada Paciente 1,
- Page 172 and 173:
165
- Page 174 and 175:
167
- Page 176 and 177:
169
- Page 178 and 179:
171
- Page 180 and 181:
173
- Page 182 and 183:
• • • •
- Page 184 and 185:
177
- Page 186 and 187:
179
- Page 188 and 189:
181
- Page 190 and 191: 183
- Page 192 and 193: 185
- Page 194 and 195: 187
- Page 196 and 197: 189
- Page 198 and 199: 191
- Page 200 and 201: SI N = 399 N=778 ¿Datos Pre-Tx? No
- Page 202 and 203: 195
- Page 204 and 205: 4.II.1. •
- Page 206 and 207: 4.II.2. • •
- Page 208 and 209: 4.II.3.
- Page 210 and 211: 4.III.1.
- Page 212 and 213: Supervivencia Acumulada Paciente 1,
- Page 214 and 215: Supervivencia Acumulada Tx Censuran
- Page 216 and 217: Supervivencia Acumulada Paciente 1,
- Page 218 and 219: Población Total N=778 Subpoblació
- Page 220 and 221: 213
- Page 222 and 223: 215
- Page 224 and 225: 217
- Page 226 and 227: ±±
- Page 228 and 229: 221
- Page 230 and 231: 4.IV.3.
- Page 232 and 233: • o o
- Page 234 and 235: 227
- Page 236 and 237: 229
- Page 238 and 239: 231
- Page 242 and 243: 235
- Page 244 and 245: 237
- Page 246: 239